PALO ALTO, Calif., Oct. 6, 2014 /PRNewswire/ -- The latest interim data from XPAND, AirXpanders Inc.'s U.S.-based, head-to-head pivotal study of its new, needle-free, patient-controlled tissue expansion system for mastectomy patients undergoing breast reconstruction, will be presented at...